Voyageur Pharmaceuticals (CVE:VM) Trading Up 24.1% – Time to Buy?

Voyageur Pharmaceuticals Ltd. (CVE:VM) rose 24.1% on Monday . The stock traded as high as C$0.18 and last traded at C$0.18. Approximately 201,820 shares traded hands during trading, an increase of 134% from the average daily volume of 86,131 shares. The stock had previously closed at C$0.15.

Voyageur Pharmaceuticals Stock Performance

The firm’s 50 day moving average price is C$0.16 and its 200-day moving average price is C$0.16. The firm has a market cap of C$31.23 million, a price-to-earnings ratio of -8.75 and a beta of 0.63. The company has a debt-to-equity ratio of 4.23, a current ratio of 0.10 and a quick ratio of 0.84.

Voyageur Pharmaceuticals Company Profile

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. was founded in 2017 and is headquartered in Calgary, Canada.